These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10414746)

  • 1. Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells.
    Engel JD; Kundu SD; Yang T; Lang S; Goodwin S; Janulis L; Cho JS; Chang J; Kim SJ; Lee C
    Urology; 1999 Jul; 54(1):164-70. PubMed ID: 10414746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.
    Kundu SD; Kim IY; Zelner D; Janulis L; Goodwin S; Engel JD; Lee C
    J Urol; 1998 Nov; 160(5):1883-8. PubMed ID: 9783979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of expression of transforming growth factor-beta type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2'-deoxycytidine.
    Zhang Q; Rubenstein JN; Liu VC; Park I; Jang T; Lee C
    Life Sci; 2005 Jan; 76(10):1159-66. PubMed ID: 15620579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
    Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
    Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
    Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
    J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
    Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
    Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
    Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
    Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
    Perry K; Wong L; Liu V; Park I; Zhang Q; Rejen V; Huang X; Smith ND; Jovanovic B; Lonning S; Teicher BA; Lee C
    Urology; 2008 Jul; 72(1):225-9. PubMed ID: 18295867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].
    Wang XD; Liu H; Cao S; Li H; Ren XB; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):405-10. PubMed ID: 17974270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
    Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
    Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
    J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.
    Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH
    Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
    Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
    J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril restores transforming growth factor-beta type II receptor and sensitivity to transforming growth factor-beta in murine renal cell cancer cells.
    Miyajima A; Asano T; Hayakawa M
    J Urol; 2001 Feb; 165(2):616-20. PubMed ID: 11176447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta receptors in verrucous and squamous cell carcinoma.
    Anderson M; Muro-Cacho C; Cordero J; Livingston S; Muñoz-Antonia T
    Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):849-54. PubMed ID: 10448730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B; Jang JS; Park K
    Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.
    Lynch MA; Petrel TA; Song H; Knobloch TJ; Casto BC; Ramljak D; Anderson LM; DeGroff V; Stoner GD; Brueggemeier RW; Weghorst CM
    Gene Expr; 2001; 9(4-5):157-71. PubMed ID: 11444526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.